Affinity Asset Advisors, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager
Affinity Asset Advisors, LLC
Reporting Manager
Affinity Healthcare Fund, LP
Security
Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
AVTX
Shares outstanding
13.2M shares
Disclosed Ownership
1.01M shares
Ownership
7.65%
Form type
SCHEDULE 13G/A
Filing time
13 Nov 2025, 17:21:05 UTC
Date of event
30 Sep 2025
Previous filing
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Affinity Healthcare Fund, LP 7.65% 1.01M 0 1.01M /s/ Andrew Weinstein Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer
Affinity Asset Advisors, LLC 7.65% 1.01M 0 1.01M /s/ Andrew Weinstein Andrew Weinstein, Chief Financial Officer and Chief Compliance Officer